Age cohort subgroups in adult acute myeloid leukemia studies - The population perspective [4]

Leukemia

Volumn 15, Issue 1, 2001, Pages 188-189

  Proctor, S J ^a   Taylor, P R A ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHROMOSOME 16; CHROMOSOME ANALYSIS; CHROMOSOME INVERSION; CHROMOSOME TRANSLOCATION 15; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; LETTER; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY;

EID: 0035141133     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401972     Document Type: Letter

References (5)

1. Results of chemotherapy for unselected patients with acute myeloblastic leukaemia: Effect of exclusions on interpretation of results
2. Underrepresentation of patients 65 years of age or older in cancer-treatment trials
3. A practical guide to population-based data collection (PACE): A process facilitating uniformity of care and research into practice
4. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRC AML 10 trial
5. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial